William Blair Has Pessimistic Outlook of LRMR Q1 Earnings
Larimar Therapeutics, Inc. (NASDAQ:LRMR – Free Report) – Research analysts at William Blair decreased their Q1 2025 EPS estimates for Larimar Therapeutics in a research note issued on Monday, March 24th. William Blair analyst M. Minter now anticipates that the company will post earnings per share of ($0.46) for the quarter, down from their previous […]
Larimar Therapeutics, Inc. (NASDAQ:LRMR – Free Report) – Research analysts at William Blair decreased their Q1 2025 EPS estimates for Larimar Therapeutics in a research note issued on Monday, March 24th. William Blair analyst M. Minter now anticipates that the company will post earnings per share of ($0.46) for the quarter, down from their previous […]
